Akesis names John L. Capicchioni as new president

Thursday, May 31, 2012 12:34 PM

Akesis, a Lake Wylie, S.C.-based contract research firm specializing in phase II-IV clinical dermatology services and regulatory affairs consulting, has appointed John L. Capicchioni as its new president.

Capicchioni will be responsible for providing strategic leadership and managerial oversight of the company while driving growth and assuring quality, cost optimization and best business practices to pharmaceutical, device, generic, formulation development and biotechnology companies.

Capicchioni brings 22 years of global CRO experience to Akesis. He has held a broad range of executive leadership positions, overseeing global sales, project management, marketing and client services. He has served as senior vice president of business development for global early clinical and bioanalytical research at MDS Pharma Services (now Celerion), where he directed the pharmaceutical and generic segments. He has also held senior posts at Phoenix International Life Sciences. Capicchioni has also served on the board of directors of the Generic Pharmaceutical Association as the elected member for CROs.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 17

PPD, Medidata join their technologies for risk-based monitoring, adaptive trial design

ERT acquires eClinical Insights in "strategic combination" to gain cloud-based trial software platform, expertise

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs